This episode of the Pharmaron DMPK Insights Podcast Series sees Josephine Bunch, Ph.D. (Principal Research Scientist and Co-Director of the National Center of Excellence in Mass Spectrometry (NiCE-MSI) at NPL and Chair of Biomolecular Mass Spectrometry at Imperial College London), discuss her work, focusing on her involvement in the Cancer Research UK Grand Challenge Programme.
The podcast also explores a range of other relevant topics, including:
- Recent developments in Mass Spectrometry Imaging (MSI)
- The challenge of analyzing increasingly complex molecules
- Label-free versus labeled imaging
- The effect of hardware and software improvements on the industry
- Leveraging combinations of different imaging techniques to extract maximum information
- Exciting future developments, including the innovative technologies set to make personalized medicine a reality
Acknowledgments
Produced from materials originally authored by Pharmaron Beijing Co., Ltd.
About Pharmaron
Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 17,000 employees, and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.